GeminIQ Website Logo

Viewing COCP free

Subscribe for full history, 90+ metrics, screener, watchlist...

Cocrystal Pharma, Inc.

COCP

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
--------18222630
Cash
2578571013--26-
Restricted Cash Current
000000000000
Value Added Tax Receivable Current
111121111111
Prepaid Expense And Other Assets Current
000000010222
Assets Current
368979121420242932
Property Plant And Equipment Net
000000000000
Deposits Assets Noncurrent
000000000000
Operating Lease Right Of Use Asset
111122222220
Assets
571010911131622273133
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current
222122222232
Operating Lease Liability Current
000000000000
Liabilities Current
322222223232
Long Term Debt
Operating Lease Liability Noncurrent
11111122222-
Liabilities Noncurrent
111-112-222-
Liabilities
433333444452
Stockholders Equity
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
349349349347343343343343343342342342
Retained Earnings Accumulated Deficit
-348-345-342-340-338-336-333-330-325-320-316-311
Stockholders Equity
146857101317232631
Liabilities And Stockholders Equity
571010911131622273133
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
100100100100100100150100150150150150
Common Stock Shares Issued
141414131010101010101010
Shares Outstanding
141414131010101010101010

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-20.00%-13.33%-31.67%---------
202513.19%5.56%28.47%-11.90%-27.98%-35.12%-0.97%-3.88%-4.85%41.58%13.86%-0.99%
202446.24%37.57%5.78%0.00%7.65%1.76%7.34%32.77%12.43%20.42%2.82%4.93%
2023----31.56%-32.23%-41.53%-8.51%-3.19%-14.36%9.29%39.29%70.71%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.24
2.66
3.68
5.78
3.69
4.57
4.77
7.32
7.41
10.30
8.92
16.74
Quick Ratio
1.14
2.48
3.53
5.47
3.54
4.37
4.59
7.06
7.27
9.63
8.37
15.78
Working Capital
620.00K
3.71M
5.92M
7.26M
4.93M
6.90M
9.15M
12.31M
17.01M
22.11M
25.83M
30.28M
Leverage & Debt
Debt to Equity
3.45
0.80
0.53
0.36
0.59
0.46
0.41
0.28
0.24
0.18
0.18
0.06
Interest Coverage TTM
-100.10
-75.92
-67.31
-68.79
-55.07
-45.37
-33.29
-29.18
-21.49
-20.47
-29.00
-39.99
Debt Ratio
0.78
0.45
0.35
0.27
0.37
0.31
0.29
0.22
0.19
0.15
0.16
0.06
Efficiency & Turnover
Asset Turnover TTM
0.05
0.02
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Per Share Metrics
Diluted EPS TTM
-0.72
-0.64
-0.78
-0.88
-1.23
-1.56
-1.72
-1.84
-1.76
-1.65
-1.86
-1.77
Free Cash Flow Per Share TTM
-0.58
-0.55
-0.73
-0.88
-1.31
-1.47
-1.62
-1.64
-1.40
-1.59
-1.53
-1.61
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Operating Profit Margin TTM
-3,063.64%
-4,015.11%
-
-
-
-
-
-
-
-
-
-
Net Profit Margin TTM
-3,011.52%
-3,924.00%
-
-
-
-
-
-
-
-
-
-
Growth Metrics
Net Income Growth (1Y)
-20.88%
-44.29%
-49.55%
-48.29%
-29.94%
-5.38%
-2.67%
3.78%
-8.32%
-57.93%
-53.69%
-52.60%
EPS Growth (1Y)
-41.62%
-58.89%
-54.54%
-52.13%
-29.94%
-5.38%
-7.67%
3.56%
-9.31%
-66.33%
-60.93%
-61.99%
Valuation Metrics
P/E TTM
-1.46
-1.58
-1.25
-1.42
-1.21
-0.91
-1.17
-0.96
-1.32
-0.85
-0.92
-1.05
P/B TTM
13.87
3.38
1.75
1.79
2.84
1.98
2.16
1.41
1.36
0.63
0.63
0.62
P/S TTM
43.87
61.88
-
-
-
-
-
-
-
-
-
-
Market Cap
14.48M
13.92M
11.06M
13.74M
15.16M
14.45M
20.55M
17.91M
23.71M
14.24M
16.60M
18.99M
Enterprise Value
12.31M
9.24M
4.04M
6.01M
10.39M
7.53M
10.69M
4.89M
5.56M
-7.60M
-9.75M
-10.75M
Calculated Values
Free Cash Flow TTM
-7.97M
-7.61M
-8.20M
-9.63M
-13.38M
-14.92M
-16.49M
-16.72M
-14.28M
-16.14M
-14.78M
-16.30M
Net Debt
-2.17M
-4.69M
-7.03M
-7.73M
-4.77M
-6.92M
-9.86M
-13.02M
-18.14M
-21.84M
-26.35M
-29.74M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-02-24Purchase
Owner: Frost, Phillip Md Et Al
Title: -
Shares: 20,000
Price/Share: $1.00
Value: $20,000.00
Shares Owned: 1,908,551
Relationship: Director,TenPercentOwner
Ownership: Indirect
2026-02-06Purchase
Owner: Frost, Phillip Md Et Al
Title: -
Shares: 50,000
Price/Share: $0.95
Value: $47,500.00
Shares Owned: 1,888,551
Relationship: Director,TenPercentOwner
Ownership: Indirect
2025-12-31Purchase
Owner: Frost, Phillip Md Et Al
Title: -
Shares: 50,000
Price/Share: $0.95
Value: $47,500.00
Shares Owned: 1,838,551
Relationship: Director,TenPercentOwner
Ownership: Indirect
2025-12-30Purchase
Owner: Frost, Phillip Md Et Al
Title: -
Shares: 20,000
Price/Share: $0.97
Value: $19,400.00
Shares Owned: 1,788,551
Relationship: Director,TenPercentOwner
Ownership: Indirect
2025-12-26Purchase
Owner: Frost, Phillip Md Et Al
Title: -
Shares: 40,000
Price/Share: $0.97
Value: $38,800.00
Shares Owned: 1,768,551
Relationship: Director,TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
5.54%
Inst. Shares: 763,124
Shares Outstanding: 13,786,000
2025-12-31
6.83%
Inst. Shares: 770,598
Shares Outstanding: 11,290,000
2025-09-30
6.05%
Inst. Shares: 664,983
Shares Outstanding: 10,991,000
2025-06-30
6.75%
Inst. Shares: 686,516
Shares Outstanding: 10,174,000
2025-03-31
7.36%
Inst. Shares: 748,773
Shares Outstanding: 10,174,000

Cocrystal Pharma, Inc. (COCP) — SEC Financial Statements & Analysis

Cocrystal Pharma, Inc. (COCP) is a pharmaceutical preparations company, incorporated in DE. Cocrystal Pharma, Inc. trades on Nasdaq as: COCP. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Cocrystal Pharma, Inc. reported a Debt-to-Equity ratio of 3.45x, a Price-to-Sales (P/S) ratio of 43.87x (TTM), a Price-to-Book (P/B) ratio of 13.87x (TTM), at a market cap of $14.48M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity
3.45x
P/S TTM
43.87x
P/B TTM
13.87x
Market Cap
$14.48M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Cocrystal Pharma, Inc. in?

Cocrystal Pharma, Inc. (COCP) operates in the Pharmaceutical Preparations industry.

What is COCP's market cap?

Cocrystal Pharma, Inc. (COCP) has a market capitalization of $14.48M as of 2026-06-30.

What exchange does COCP trade on?

Cocrystal Pharma, Inc. (COCP) trades on the Nasdaq.

Where is Cocrystal Pharma, Inc. incorporated?

Cocrystal Pharma, Inc. is incorporated in DE.

Wall Street's data.
Main Street's price.